Per-Anders Abrahamsson, MD, PhD

Ferring Pharmaceuticals A/S

Copenhagen, Denmark

Per-Anders Abrahamsson, MD, PhD, is a Professor of Urologic Oncology and past-Chairman of the Department of Urology at Lund University in Lund, Sweden. He is also Vice President of Global Medical Affairs at Ferring Pharmaceuticals A/S in Copenhagen, Denmark, and was Secretary General of the European Association of Urology (EAU) from 2007-2015. In addition, Professor Abrahamsson is an Adjunct Professor in Urology at the University of Rochester Medical Center in Rochester, New York.

Disclosures:

Articles by Per-Anders Abrahamsson, MD, PhD

An Update of the European/Swedish Screening Trial

Posted by Per-Anders Abrahamsson, MD, PhD | Apr 2017

Professor Per-Anders Abrahamsson, MD, PhD presented “An Update of the European/Swedish...

Join the GRU Community

- Why Join? -

CARDEN JENNINGS PUBLISHING CO., LTD.

Your GRU

– Account Dashboard
– Your Courses

Recent Updates

PDF Embedder Test Jan 2022
Genetic Testing and Prostate Cancer – Welcome Jan 2022
Current Status of PSMA Diagnostics Aug 2021
Genetic Testing and Prostate Cancer Aug 2021
What’s New in Active Surveillance for Prostate Cancer in 2021 Aug 2021

Per-Anders Abrahamsson, MD, PhD

Ferring Pharmaceuticals A/S

Copenhagen, Denmark

Articles by Per-Anders Abrahamsson, MD, PhD

An Update of the European/Swedish Screening Trial

Join the GRU Community

You have Successfully Subscribed!

CARDEN JENNINGS PUBLISHING CO., LTD.

INFO

Your GRU

– Account Dashboard
– Your Courses

Recent Updates

Exercise & Wellness

Per-Anders Abrahamsson, MD, PhD

Ferring Pharmaceuticals A/S

Copenhagen, Denmark

Articles by Per-Anders Abrahamsson, MD, PhD

An Update of the European/Swedish Screening Trial

Join the GRU Community

You have Successfully Subscribed!

CARDEN JENNINGS PUBLISHING CO., LTD.

INFO

Your GRU

– Account Dashboard – Your Courses

Recent Updates

Exercise & Wellness

– Account Dashboard
– Your Courses